Millennium Management’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Millennium Management’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-273,286	Closed	-$7.13M	–	4760
2019 Q1	$7.13M	Buy	273,286 +248,426	+999%	+$4.64M	0.01%	1516
2018 Q4	$292K	Buy	+24,860	New	+$309K	﹤0.01%	3228
2018 Q1	–	Sell	-10,319	Closed	-$196K	–	4304
2017 Q4	$196K	Sell	10,319 -181,655	-95%	-$3.04M	﹤0.01%	3539
2017 Q3	$3.24M	Buy	+191,974	New	+$3.14M	﹤0.01%	1905

Millennium Management's CMTA Position: Q2 2019 in Review

Millennium Management sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 273,286 shares — an estimated $7.13M sold.

Millennium Management first reported a position in CMTA in Q3 2017 and held it in 4 quarters. The position peaked at $7.13M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Millennium Management reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Millennium Management sold 273,286 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $7.13M.
Millennium Management first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 4 quarters.
Millennium Management's Clementia Pharmaceuticals Inc. position peaked at $7.13M in Q1 2019.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.